Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Leiomyomas
Interventions
PROCEDURE

Diffusion -and perfusion weighted MRI including iv contrast agent injection

"MRI is a technique based on magnetic fields and does not require the use of ionizing radiation. Although there are no known side effects associated with MRI, a few precautions should be taken because of the 3T magnetic field. This implicates that all metal and magnetized objects must be removed from the patients before entering the MRI room. Patients with a pacemaker, a cardiac defibrillator or other implanted conductors/prostheses are for reason not eligible for the study.~During the MRI examination, an intravenous contrast agent will be administered. In most cases, patients do not experience any discomfort and the use of this contrast agent is part of the clinical routine."

Trial Locations (1)

3000

Radiology Department, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01514617 - Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization | Biotech Hunter | Biotech Hunter